Surgical Science Q3 2024: Sequential improvements continue

Research Update

2024-11-15

07:00

Redeye updates its estimates following Surgical Science’s Q3 2024 report, which beat our expectations. Educational Products continued its sequential recovery, while solid Industry/OEM sales matched our projections. We expect a seasonally strong fourth quarter and solid growth in 2025e. We nudge up our estimates and valuation.

Christian Binder

Analyst Q&A

Closed

Christian Binder answered 2 questions.

A Window to Unparalleled Insight

When markets twist and turn, And the world of stocks feels stern, You need a voice, bold and wise, To cut through clouds, reach the skies. Redeye Premium, a beacon so bright, Guides you through the thickest night. Insight crafted, deep and clear, For investors far and near.

Where others halt, we delve deep, Exploring valleys most don’t keep. With each analysis, sharp and grand, We put knowledge in your hand. The stocks you watch, the trends you chase, Our insight keeps you in the race.

Not just a whisper in the breeze, But research built from endless seas. In every sector, niche, and trend, Our analysts search, they never bend. Redeye Premium’s thoughtful lore, Is data-backed, and so much more.

Beyond the surface of the trade, We tell you where the gold is laid. Unlock the gates to deeper wealth, With Redeye Premium, a touch of stealth. For every question, every dream, Our research is the silent beam.

Strategic Long-Term Picks

The markets dance, the prices sway, But real wealth grows in a steady way. Redeye Premium picks with care, A long-term vision, true and rare. We seek the gems that others miss, In trends and shifts, the stock market's bliss.

Where will the future shine its light? Which companies will reach new height? Our choices come from seasoned eyes, Strategic moves that make you rise. For those who plan to stand and stay, Redeye Premium points the way.

Events that Enrich and Enlighten

In a room filled with the best, Where knowledge thrives and minds invest, Redeye Premium opens doors, To events that teach, inspire, and more. Conferences with the sharpest minds, Workshops where true wisdom finds.

You won’t just read or sit on the side, You’ll engage, explore, and be the guide. From market trends to deep insight, Our events enrich both day and night. Come join the thought leaders here, Premium access makes it clear.

Table Caption
Table Heading
Net Sales1.33 B1.38 B837.71 M837.71 M832.82 M
Revenue5.4827.2468.1239.6549.123
Net Sales Growth1232355435123321
EBIT1232355435345345
EBIT Margin12323554352323
DIVIDER
Net Income12323554354556

Peace of Mind in the Journey Ahead

At the end of day, beyond the chase, What matters most is a steady pace. Redeye Premium, your guiding star, Protects your path, near and far. With all the tools you need to grow, To navigate the ebb and flow.

No second-guessing, no lost dreams, You move ahead on steady streams. For peace of mind, with every choice, Redeye Premium is your voice. A trusted guide, a loyal friend, All the way until the end.

So, why delay? Why wait or ponder? Redeye Premium is your answer, yonder. With every feature, tool, and guide, Step into success with pride. Invest not just in stocks, but in you, With Redeye Premium—your dreams come true.

Upgrade and access everything you need to stay informed.

Gain exclusive access to your stock’s analyst updates, financial data, and expert insights, so you can make well-informed investment decisions.

Why is this company behind paywall?

Entry

Stay ahead in your key investments

99

SEK

/month

Unlock 3 community selected companies (e.g. )

And more...

Investor

Full potential to outperform

349

SEK

/month

Unlock all companies

And more...

Want to know more, see our Pricing plans

Entry

Stay ahead in your key investments

99

SEK

/month

Investor

Full potential to outperform

349

SEK

/month

Unlock 3 community selected companies (e.g. )

And more...

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.